Label-free detection of prostate cancer and benign prostatic hyperplasia based on SERS spectroscopy of Plasma

In this work, Surface-enhanced Raman spectroscopy (SERS) involving blood plasma was investigated; the objective was to determine whether this approach could distinguish prostate cancer with benign prostatic hyperplasia. The experimental samples were prepared by blood plasma mixed with the silver colloid over an aluminum plate substrate. A total of 14 SERS spectra for prostate cancer (PCa) and 14 spectra for benign prostatic hyperplasia (BPH) were successfully gathered from patients who came from Fujian Provincial Hospital. Difference spectrum analysis combined with the assignment of Raman bands indicated that there were subtle but distinct changes between prostate cancer (PCa) and benign prostatic hyperplasia (BPH), which could be related to the level of prostate specific antigen (PSA); because it has been reported that the level of PSA is increased in men who have prostate cancer compared with those with benign prostatic hyperplasia (BPH). To further make clear the difference of Prostate cancer (PCa) and benign prostatic hyperplasia (BPH), the spectral data was combined with multivariate analysis processes. Principal component analysis (PCA), as a spectral dimensionality reduction approach, and in conjunction with linear discriminant analysis (LDA) were employed to identify the samples, to build diagnostic algorithms. The leave-one-out cross-validation method was used to validate the diagnostic algorithms; the result showed that a sensitivity of 95.8% and a specificity of 100.0% which indicated can significantly differentiate PCa and BPH groups. In addition, we further verify the validity of the diagnosis algorithm based on PCA-LDA diagnosis algorithm by using receiver operating characteristic (ROC) curves. The results of experiment study suggest that SERS combined with PCA-LDA algorithms has great potential for clinical screening of benign prostate hyperplasia and prostate cancer.

[1]  M. A. Jiménez,et al.  Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients , 2018, Clinical genitourinary cancer.

[2]  D. McKenna,et al.  Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review , 2020, Cancer management and research.

[3]  Hugh Barr,et al.  Near‐infrared Raman spectroscopy for the classification of epithelial pre‐cancers and cancers , 2002 .

[4]  Rina K. Dukor,et al.  Vibrational Spectroscopy in the Detection of Cancer , 2006 .

[5]  Andrew J. Vickers,et al.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.

[6]  Yu Zeng,et al.  Label-free detection of multiple genitourinary cancers from urine by surface-enhanced Raman spectroscopy. , 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[7]  Rong Chen,et al.  Near-infrared confocal micro-Raman spectroscopy combined with PCA–LDA multivariate analysis for detection of esophageal cancer , 2013 .

[8]  L L Hench,et al.  Discrimination between ricin and sulphur mustard toxicity in vitro using Raman spectroscopy , 2004, Journal of The Royal Society Interface.

[9]  S. Lane,et al.  Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. , 2006, Biophysical journal.

[10]  Wen-ting Cheng,et al.  Micro‐Raman spectroscopy used to identify and grade human skin pilomatrixoma , 2005, Microscopy research and technique.

[11]  H. Barr,et al.  Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus , 2006, British Journal of Cancer.

[12]  Christopher J. Frank,et al.  Raman spectroscopy of normal and diseased human breast tissues. , 1995, Analytical chemistry.

[13]  Namhyun Choi,et al.  Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer. , 2017, ACS nano.

[14]  R. Dasari,et al.  Prospects for in vivo Raman spectroscopy , 2000 .

[15]  Jeremy J. Baumberg,et al.  Present and Future of Surface-Enhanced Raman Scattering , 2019, ACS nano.